Table 5.
Human Papillomavirus Type 16 DNA Load of the Newly Detected Infection in Women Who Continued to Be Positive Compared With Those Who Became Negative at Subsequent Visit
| No. of Visits Subsequent to Newly Detected Infection | No. Excluded a | Remaining Positive |
Becoming Negative |
Pb | ||
| no. | Log10 Viral Copies/ng of Cellular DNA (Mean Load ± SD) | no. | Log10 Viral Copies/ng of Cellular DNA (Mean Load ± SD) | |||
| 1 | 13 | 47 | 2.26 ±1.71 | 34 | .76 ±1.14 | .001 |
| 2 | 22 | 17 | 1.79 ±1.36 | 8 | 1.92 ±1.54 | .79 |
| 3 | 7 | 3 | 2.06 ±2.27 | 7 | 1.25 ±1.08 | .45 |
NOTE. Data are from 94 women with a newly detected infection prior to the last follow-up visit.
Excluded were women who did not return for follow-up at the visit evaluated or who had CIN3 diagnosed one visit before.
Adjusted for smoking status at enrollment and cytologic findings at the follow-up visits from which samples were assayed for viral load for analyses of retaining viral load–related positivity at subsequent visits 1 and 2 but not visit 3 (due to the small number of women seen at this visit).